Hosted on MSN11mon
ARS Pharma Readies Data In Response To FDA's Rejection For Its EpiPen Alternative For Severe Allergic Reactionsto repeat doses of epinephrine intramuscular (IM) injection. ARS Pharma intends to submit this repeat-dose NAC study data to the FDA as part of its response to the CRL early in the second quarter ...
This is the first large-scale study to compare different types of fat distribution in the body (intramuscular vs. subcutaneous) and provides insight into how we might better assess someone’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results